» Articles » PMID: 26824863

Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts Through S1P1 Activation

Overview
Journal PLoS One
Date 2016 Jan 30
PMID 26824863
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid involved in several physiological processes including cell migration and differentiation. S1P signaling is mediated through five G protein-coupled receptors (S1P1-S1P5). S1P1 is crucial to the exit of T-lymphocytes from the thymus and peripheral lymphoid organs through a gradient of S1P. We have previously observed that T-ALL and T-LBL blasts express S1P1. Herein we analyzed the role of S1P receptors in the migratory pattern of human T-cell neoplastic blasts. S1P-triggered cell migration was directly related to S1P1 expression. T-ALL blasts expressing low levels of S1P1 mRNA (HPB-ALL) did not migrate toward S1P, whereas those expressing higher levels of S1P1 (MOLT-4, JURKAT and CEM) did migrate. The S1P ligand induced T-ALL cells chemotaxis in concentrations up to 500 nM and induced fugetaxis in higher concentrations (1000-10000 nM) through interactions with S1P1. When S1P1 was specifically blocked by the W146 compound, S1P-induced migration at lower concentrations was reduced, whereas higher concentrations induced cell migration. Furthermore, we observed that S1P/S1P1 interactions induced ERK and AKT phosphorylation, and modulation of Rac1 activity. Responding T-ALL blasts also expressed S1P3 mRNA but blockage of this receptor did not modify migratory responses. Our results indicate that S1P is involved in the migration of T-ALL/LBL blasts, which is dependent on S1P1 expression. Moreover, S1P concentrations in the given microenvironment might induce dose-dependent chemotaxis or fugetaxis of T-ALL blasts.

Citing Articles

Intrathymic Cell Migration: Implications in Thymocyte Development and T Lymphocyte Repertoire Formation.

Mendes-da-Cruz D, Lemos J, Belorio E, Savino W Adv Exp Med Biol. 2025; 1471:139-175.

PMID: 40067586 DOI: 10.1007/978-3-031-77921-3_5.


S1PR-1/5 modulator RP-101074 shows beneficial effects in a model of central nervous system degeneration.

Sindi M, Hecker C, Issberner A, Ruck T, Meuth S, Albrecht P Front Immunol. 2023; 14:1234984.

PMID: 37638037 PMC: 10450045. DOI: 10.3389/fimmu.2023.1234984.


Sphingosine-1-phosphate Treatment Improves Cryopreservation Efficiency in Human Mesenchymal Stem Cells.

Oh S, Jo C, Kim T, Hong C, Lee S, Kang Y Life (Basel). 2023; 13(6).

PMID: 37374070 PMC: 10302647. DOI: 10.3390/life13061286.


Differential Upregulation and Functional Activity of S1PR1 in Human Peripheral Blood Basophils of Atopic Patients.

Gray N, Limberg M, Wiebe D, Weihrauch T, Langner A, Brandt N Int J Mol Sci. 2022; 23(24).

PMID: 36555755 PMC: 9785255. DOI: 10.3390/ijms232416117.


Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro.

Testa S, Haabeth O, Blake T, Del Castillo T, Czerwinski D, Rajapaksa R Biomacromolecules. 2022; 23(7):2976-2988.

PMID: 35748182 PMC: 10199726. DOI: 10.1021/acs.biomac.2c00469.


References
1.
Beillard E, Pallisgaard N, van der Velden V, Bi W, Dee R, van der Schoot E . Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia. 2003; 17(12):2474-86. DOI: 10.1038/sj.leu.2403136. View

2.
Minowada J, Onuma T, Moore G . Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972; 49(3):891-5. View

3.
Samstag Y, Eibert S, Klemke M, Wabnitz G . Actin cytoskeletal dynamics in T lymphocyte activation and migration. J Leukoc Biol. 2003; 73(1):30-48. DOI: 10.1189/jlb.0602272. View

4.
Pappu R, Schwab S, Cornelissen I, Pereira J, Regard J, Xu Y . Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science. 2007; 316(5822):295-8. DOI: 10.1126/science.1139221. View

5.
Evangelisti C, Evangelisti C, Teti G, Chiarini F, Falconi M, Melchionda F . Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. Oncotarget. 2014; 5(17):7886-901. PMC: 4202168. DOI: 10.18632/oncotarget.2318. View